Tizanidine Tablet
Product Images NDC 71205-311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71205-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
This is a report on the improvement of Ashworth score. The report includes data on the mean dose of 26.8mg and shows observations at the end of titration, end of maintenance, and endpoint.*
FDA Label Image

71205-311-30 (Tizanidine 5)

71205-311-30 (Tizanidine 5)
This is the description of a medication with the name Tizanidine 2mg. It comes in the form of tablets, and each tablet has 2.288 mg tizanidine HCI, USP equivalent to 2 mg of tizanidine base. The medication is white to off-white, round, flat beveled, uncoated tablets debossed with product code "502" on one side, and bisecting score on the other. This medication is not interchangeable with Tizanidine Capsules. The medication is produced by ALKALOIDA Chemical Company Zrt 4440 Tiszavasvéri, Kabay Janos u. 29, Hungary, and packaged by Proficent Rx LP Thousand Oaks, CA 91320. The medication should be stored at 25°C (77°F) and kept out of the reach of children. There are three different lots mentioned with the packaging details of this medication. The GTIN number mentioned is 0037120531308.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.